Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace

Core Insights - Fifty1 Labs, Inc. clarifies that no formal partnership or collaboration has been established with LUNR Aerospace, and there is no current intent to form one [1] - The company has undergone leadership changes, with Dr. Joel Gagnier now serving as CEO following the resignation of Mr. Arora on December 1, 2025 [1] - Fifty1 Labs has divested from its subsidiary Fifty1 AI Labs as of December 3, 2025, resulting in no overlap in ownership, management, or operations between the two entities [1] Company Overview - Fifty1 AI Labs, previously a subsidiary of Fifty1 Labs, focuses on redefining drug discovery through AI, aiming to repurpose safe, off-patent compounds to create smarter therapies that enhance patient outcomes and reduce costs [2] - LUNR Aerospace is a Canadian space technology company based in Vancouver, specializing in aerospace innovations [3]